DEprescribing: Perceptions of PAtients living with advanced cancer. A multicentre, prospective mixed observational study protocol.
Adrien Evin, Marianne Bourdon, Pierre Nizet...
https://pubmed.ncbi.nlm.nih.gov/39163415/Actively Recruiting
Led by Nantes University Hospital · Updated on 2026-09-25
325
Participants Needed
8
Research Sites
118 weeks
Total Duration
Researchers are investigating patients perceptions of deprescribing in palliative cancer care. This observational study aims to better understand how patients with advanced cancer view the reduction of unnecessary medications, known as deprescribing, and to explore factors influencing their attitudes and beliefs. The study also evaluates the use of a validated questionnaire, the rPATD, in this population and includes an ancillary study on the link between health literacy and deprescribing perceptions. The study is conducted in two phases over three years. The first is a qualitative phase involving semi-directed individual interviews with about 25 patients over eight months. The second phase is quantitative, involving self-administered questionnaires including the rPATD and the Beliefs about Medicine Questionnaire BMQ given to 300 patients over 12 months. The ancillary study assessing health literacy is carried out during this second phase using a validated 14-item questionnaire. Participants will be involved through interviews and questionnaire completion, providing insight into their medication beliefs and health literacy. Researchers collect data on patients perceptions, attitudes, and psychometric properties of the questionnaires. The studys findings aim to guide better approaches to reduce polymedication and improve quality of life and safety in palliative oncology care. The total study duration spans three years from start to completion.
CONDITIONS
DEprescribing: Perceptions of PAtients Living With Advanced Cancer
A
Adrien EVIN, MCU-PH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nantes University Hospital
Lead Sponsor
Fondation de France
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 months
Participants take part in semi-directed individual interviews to share their perceptions of deprescribing.
Around 25 individual interviews
Duration - 12 months
Participants complete self-administered questionnaires about medication beliefs and health literacy.
Questionnaires administered to 300 patients
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Adrien Evin, Marianne Bourdon, Pierre Nizet...
https://pubmed.ncbi.nlm.nih.gov/39163415/Nantes University Hospital
Lead Sponsor
Fondation de France
Collaborating Sponsor